Belatacept denied as not medically necessary by UnitedHealthcare?

UnitedHealthcare's specific coverage criteria for belatacept are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why UnitedHealthcare Denies Belatacept on Medical-Necessity Grounds

Belatacept is a biologic immunosuppressant approved for prophylaxis of organ rejection in adult kidney transplant recipients. UnitedHealthcare's medical-necessity denials for belatacept typically arise because the insurer's coverage policy requires documentation that the patient meets specific transplant-recipient criteria and that alternative, less costly immunosuppressive regimens have been considered or found inappropriate. Reviewers often cite incomplete documentation of the clinical rationale for selecting belatacept over standard calcineurin-inhibitor–based protocols.

## Why This Denial Is Appealable

A medical-necessity denial is a coverage determination, not a final clinical verdict. If your transplant team believes belatacept is the medically appropriate choice for your specific clinical circumstances, that judgment is documentable and contestable. Federal law guarantees your right to a full internal appeal and, if that fails, an independent external review.

## Federal Appeal Framework

• ACA §2719 / PPACA external review: Non-grandfathered individual and group plans must offer binding external review by an accredited Independent Review Organization (IRO). You generally have approximately four months from receiving a denial to request external review, though you should confirm the exact deadline printed on your Explanation of Benefits (EOB).
• ERISA §503 (employer-sponsored plans): Requires a full-and-fair review with access to the clinical criteria used. The plan must provide the specific guideline or policy on which the denial was based.
• Expedited review: If your clinical situation is urgent — for example, a transplant patient at risk of acute rejection — request expedited internal and external review simultaneously.

## Concrete Appeal Steps

1. Request the denial letter and the full UnitedHealthcare medical policy governing belatacept in writing. 2. Ask your transplant physician to draft a medical-necessity letter that responds point-by-point to each criterion listed in that policy. 3. Compile the documentation categories below. 4. Submit your internal appeal within the deadline on your EOB (typically 180 days). 5. If the internal appeal is denied, immediately file for external IRO review.

## Documentation to Gather

• Diagnosis and transplant confirmation: operative report, pathology, current transplant status records.
• Prior immunosuppression history: names of all regimens tried, start/stop dates, documented intolerances, toxicities, or rejection episodes with chart notes.
• Clinical severity: most recent labs, biopsy results if applicable, any documentation of calcineurin-inhibitor nephrotoxicity or contraindication per your physician's assessment.
• Prescriber medical-necessity letter: should state why belatacept is appropriate for this patient's clinical profile, referencing the FDA-approved prescribing information and the relevant transplant society guideline (e.g., the applicable KDIGO or AST guideline) without asserting specific numbers — let the chart facts speak.

## Criteria-Mapping Structure

Obtain the exact list of coverage criteria from UnitedHealthcare's published coverage determination guideline and from the FDA-approved belatacept prescribing label. For each requirement listed, create a two-column table: the policy criterion on the left, the corresponding chart fact (with date and source document) on the right. This structure shows the IRO reviewer exactly how your case satisfies each element and prevents the plan from claiming criteria were not addressed.